FDA — authorised 15 June 2011
- Application: BLA125288
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: NULOJIX
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Nulojix in United States
FDA authorised Nulojix on 15 June 2011
Marketing authorisation
Nulojix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Nulojix approved in United States?
Yes. FDA authorised it on 15 June 2011.
Who is the marketing authorisation holder for Nulojix in United States?
BRISTOL MYERS SQUIBB holds the US marketing authorisation.